Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sporoderm Disruption Reshapes the Chemical Characteristics and Enhances the Mitochondrial Protective Activity of <i>Ganoderma lucidum</i> Spore Polysaccharides via SIRT1/AMPK Signaling.

International journal of molecular sciences·2026

Same author

Edible Fungus Compound Cordycepin Protects Against Acetaminophen-Induced Liver Injury.

Journal of clinical laboratory analysis·2026

Same author

Exploring and Targeting the Connection of Iron and Copper Homeostasis to Neurodegenerative Diseases.

MedComm·2026

Same author

5' UTR introns reduce nuclear transgene silencing and enable robust protein expression in Chlamydomonas reinhardtii.

Cell reports·2026

Same author

Andrographolide attenuates pulmonary fibrosis by covalently targeting Ptges3 and disrupting the Ptges3-Hsp90-NF-κB axis.

Journal of advanced research·2026

Same author

Antifungal Activity and Biochemical Mechanisms of Artemisinin Against the Phytopathogen <i>Sclerotinia sclerotiorum</i>.

International journal of molecular sciences·2026

Search research articles

Related Experiment Video

Updated: Oct 27, 2025

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Study towards improving artemisinin-based combination therapies.

Hai-Ning Lyu¹, Nan Ma¹, Yuqing Meng¹

¹Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. ccxu@icmm.ac.cn yytu@icmm.ac.cn jgwang@icmm.ac.cn.

Natural Product Reports

|July 21, 2021

Summary

This summary is machine-generated.

Artemisinin-based combination therapies (ACTs) are vital for malaria control. Ongoing research focuses on improving ACTs to overcome challenges like delayed parasite clearance and enhance treatment efficacy.

More Related Videos

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Related Experiment Videos

Last Updated: Oct 27, 2025

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Area of Science:

Pharmacology
Infectious Diseases
Global Health

Background:

Artemisinin derivatives have been crucial in global malaria control since their discovery.
Artemisinin-based combination therapies (ACTs) were recommended by the WHO in 2006 and remain the primary treatment for uncomplicated malaria.
Concerns regarding delayed parasite clearance with 3-day ACT treatments in Southeast Asia necessitate further optimization.

Purpose of the Study:

To provide an updated account of ongoing efforts to improve artemisinin-based combination therapies (ACTs).
To enhance the efficacy of malaria treatments.
To address challenges in current antimalarial drug therapies.

Main Methods:

Review of strategies for optimizing artemisinin-based therapies.
Exploration of synthesizing novel artemisinin derivatives.
Investigation of advanced drug delivery systems for antimalarials.
Analysis of diversifying artemisinin partner drugs.

Main Results:

Significant advancements have been made in developing improved artemisinin derivatives.
New drug delivery systems show promise for enhanced antimalarial efficacy.
Diversification of partner drugs offers potential for overcoming resistance.
Continuous efforts are focused on improving ACT efficacy.

Conclusions:

Optimizing artemisinin-based therapies is essential for sustained malaria control.
Further research into novel derivatives, delivery systems, and partner drugs is critical.
Improving ACTs will enhance treatment outcomes and combat malaria globally.